SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367644-23-000038
Filing Date
2023-02-27
Accepted
2023-02-27 20:24:01
Documents
1
Period of Report
2023-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167754742435549.html 4  
1 FORM 4 wf-form4_167754742435549.xml 4 4609
  Complete submission text file 0001367644-23-000038.txt   5969
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DRIVE, SUITE 400 GAITHERSBURG MD 20879
Business Address
Strei Katherine (Reporting) CIK: 0001709639 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 23677814